Objective: In literature, sacrum tumors and its surgery are very few. Primary tumors of sacrum are less common than metastatic tumors. In this study, it was aimed to evaluate the characteristics and the surgical site infections after surgery of the cases operated with benign/malign primer sacrum tumor.
Material and Methods: We retrospectively reviewed records of cases of operated with diagnosed by pathological examination benign/malign primer sacrum tumors in our clinic between the years of 2012 and 2018. The demographic characteristics of the cases, comorbid diseases, applied surgical treatment modalities, post-operative surgical site infection frequency, post operative features of wound site, vital findings of cases, duration of post-operative infection development, causative microorganism agents in infection, the incidence, duration and causative microorganism of recurrent infections and the survival for five years were evaluated.
Results: A total of 9 cases [five male, four female, mean age 38 years (21-74)] were included. 3 cases (33,3%) were cordoma, 3 cases (33,3%) were ewing sarcoma, one case (11,1%) malignant schwannom, one case (11,1%) giant cell tumor and one case (11,1%) were diagnosed with chondrosarcoma in their pathological examinations. Eight patients (88.9%) with malign tumor underwent extensive resection in 6 patients and one patient (11.1%) with intralesional curettage with benign tumor diagnosis. Six of the cases (66.7%) developed surgical site infection after the surgery. Infection was detected in 3 (75%) of the cases who recieved the pre-op and/or post-op radiotherapy and chemotherapy but in all underwent implantation during the surgery. Overall survival was 77.7% at 5 years and 83.3% in who developed surgical site infection.
Conclusion: As in
the sacrectomy, infections after operations in the operations with extensive resection and close rectal
proximity are common problems. Besides antibiotic therapy co-administration of surgical debridement
is also important for efficacy in the treatment of surgical site infection.